Literature DB >> 3381880

Neocortical morphometry and cholinergic neurochemistry in Pick's disease.

L A Hansen1, R Deteresa, H Tobias, M Alford, R D Terry.   

Abstract

With a computerized image-analysis apparatus for neocortical morphometry and chemical methods for evaluation of the cholinergic system, five brain specimens of Pick's disease (PD) were studied and the results compared to those from specimens of age-matched normal subjects and Alzheimer's disease (AD). The PD specimens showed major reductions in brain weight, frontal and temporal cortical thickness, and large neuron populations, compared with controls. Lesser reductions were seen in small neurons and thickness of the inferior parietal cortex. The authors found no relationship between age of onset or disease duration and either the degree of cortical thinning or neuron loss or the number of Pick bodies in the neocortex and hippocampus. PD specimens were more atrophic than AD brains, having lower brain weights and more fronto-temporal thinning. Large neurons were comparably reduced in the two conditions in the frontal and temporal lobes, but small neuron losses were greater in the PD midfrontal area. Only the AD cases showed loss of large neurons in the inferior parietal region. Levels of choline acetyltransferase were normal in PD and reduced in AD, whereas muscarinic receptor binding was decreased in both.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3381880      PMCID: PMC1880699     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  29 in total

1.  Pick's disease. Histological and clinical correlations.

Authors:  J Constantinidis; J Richard; R Tissot
Journal:  Eur Neurol       Date:  1974       Impact factor: 1.710

2.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

3.  Neurochemical observations in a case of Pick's disease.

Authors:  C M Yates; J Simpson; A F Maloney; A Gordon
Journal:  J Neurol Sci       Date:  1980-11       Impact factor: 3.181

4.  Neurotransmitter-related enzymes in senile dementia of the Alzheimer type.

Authors:  P Davies
Journal:  Brain Res       Date:  1979-08-03       Impact factor: 3.252

5.  Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies.

Authors:  D M Bowen; C B Smith; P White; A N Davison
Journal:  Brain       Date:  1976-09       Impact factor: 13.501

6.  Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer's-type dementia brains.

Authors:  P Davies; A H Verth
Journal:  Brain Res       Date:  1977-12-16       Impact factor: 3.252

7.  Radiochemical micro assays for the determination of choline acetyltransferase and acetylcholinesterase activities.

Authors:  F Fonnum
Journal:  Biochem J       Date:  1969-11       Impact factor: 3.857

8.  Fibrous Astrocytes in senile dementia of the Alzheimer type.

Authors:  R Schechter; S H Yen; R D Terry
Journal:  J Neuropathol Exp Neurol       Date:  1981-03       Impact factor: 3.685

9.  Some morphometric aspects of the brain in senile dementia of the Alzheimer type.

Authors:  R D Terry; A Peck; R DeTeresa; R Schechter; D S Horoupian
Journal:  Ann Neurol       Date:  1981-08       Impact factor: 10.422

10.  Neocortical cholinergic neurons in elderly people.

Authors:  P White; C R Hiley; M J Goodhardt; L H Carrasco; J P Keet; I E Williams; D M Bowen
Journal:  Lancet       Date:  1977-03-26       Impact factor: 79.321

View more
  12 in total

Review 1.  Abhorring the vacuum: use of Alzheimer’s disease medications in frontotemporal dementia.

Authors:  Geoffrey A Kerchner; Maria Carmela Tartaglia; Adam Boxer
Journal:  Expert Rev Neurother       Date:  2011-05       Impact factor: 4.618

Review 2.  Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management.

Authors:  Gil D Rabinovici; Bruce L Miller
Journal:  CNS Drugs       Date:  2010-05       Impact factor: 5.749

Review 3.  Medical management of frontotemporal dementias: the importance of the caregiver in symptom assessment and guidance of treatment strategies.

Authors:  Gregory A Jicha
Journal:  J Mol Neurosci       Date:  2011-06-07       Impact factor: 3.444

4.  Management of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic options.

Authors:  Gregory A Jicha; Peter T Nelson
Journal:  Neurodegener Dis Manag       Date:  2011-04

5.  Quantitative neuropathologic analysis of Pick's disease cases: cortical distribution of Pick bodies and coexistence with Alzheimer's disease.

Authors:  P R Hof; C Bouras; D P Perl; J H Morrison
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 6.  Diagnosis and management of behavioral variant frontotemporal dementia.

Authors:  Peter S Pressman; Bruce L Miller
Journal:  Biol Psychiatry       Date:  2013-11-13       Impact factor: 13.382

Review 7.  A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia.

Authors:  Edward D Huey; Karen T Putnam; Jordan Grafman
Journal:  Neurology       Date:  2006-01-10       Impact factor: 9.910

8.  Update on Major Neurocognitive Disorders.

Authors:  Kristin C Jones
Journal:  Focus (Am Psychiatr Publ)       Date:  2021-07-09

Review 9.  Neuropathology of non-Alzheimer degenerative disorders.

Authors:  Dennis W Dickson
Journal:  Int J Clin Exp Pathol       Date:  2009-08-25

Review 10.  Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance.

Authors:  Changiz Geula; Sara R Dunlop; Ivan Ayala; Allegra S Kawles; Margaret E Flanagan; Tamar Gefen; Marek-Marsel Mesulam
Journal:  J Neurochem       Date:  2021-08-06       Impact factor: 5.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.